本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Hepion Pharmaceuticals, Inc.

0.0550
0.0000
成交量:861.00
成交額:47.36
市值:63.91萬
市盈率:-0.06
高:0.0550
開:0.0550
低:0.0550
收:0.0550
52周最高:0.7464
52周最低:0.0330
股本:1,162.03萬
流通股本:1,162.03萬
量比:0.30
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-0.8800
每股收益(LYR):-107.3480
淨資產收益率:-2058.63%
總資產收益率:-100.37%
市淨率:0.66
市盈率(LYR):0.00

資料載入中...

2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

重要事件披露

8-K - Current report
2021/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

重要事件披露

8-K - Current report
2020/12/29

重要事件披露

8-K - Current report
2020/12/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/22

重要事件披露

8-K - Current report
2020/12/10

重要事件披露

8-K - Current report
2020/12/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

重要事件披露

8-K - Current report
2020/11/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/20

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/20

重要事件披露

8-K - Current report
2020/11/18

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses